欧林生物
(688319)
| 流通市值：26.23亿 | | | 总市值：36.96亿 |
| 流通股本：2.88亿 | | | 总股本：4.06亿 |
| 报告期 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 70,798,700.81 | 496,118,667.03 | 352,299,329.93 | 233,199,414.85 |
| 营业收入 | 70,798,700.81 | 496,118,667.03 | 352,299,329.93 | 233,199,414.85 |
| 二、营业总成本 | 109,128,006.76 | 490,851,002.62 | 328,847,307.58 | 196,436,358.93 |
| 营业成本 | 5,356,618.81 | 31,998,151.23 | 25,072,800.54 | 16,219,984.19 |
| 税金及附加 | 402,426.72 | 3,322,399.25 | 2,092,341.55 | 1,669,358.08 |
| 销售费用 | 23,923,785.82 | 257,806,065.58 | 160,313,438.2 | 102,287,074.54 |
| 管理费用 | 29,430,197.27 | 78,313,262.91 | 58,158,717.59 | 33,110,273.65 |
| 研发费用 | 47,738,722.74 | 114,729,216.26 | 80,280,605.06 | 41,569,336.28 |
| 财务费用 | 2,276,255.4 | 4,681,907.39 | 2,929,404.64 | 1,580,332.19 |
| 其中:利息费用 | 2,790,891.37 | 7,178,400.62 | 4,542,652.92 | 2,859,008.84 |
| 其中:利息收入 | 514,635.97 | 2,553,649.43 | 1,927,231.98 | 1,506,722.94 |
| 加:投资收益 | 18,657.53 | 1,041,729.01 | 1,017,632.88 | 644,728.77 |
| 资产处置收益 | - | -149,543.14 | -149,543.14 | -149,834.4 |
| 资产减值损失(新) | 6,232,979.5 | -4,727,853.13 | 2,264,370.96 | 1,338,921.49 |
| 信用减值损失(新) | 2,638,065.18 | -1,586,881.84 | -9,195,042.98 | -16,794,056.79 |
| 其他收益 | 1,129,014.07 | 3,253,294.04 | 2,705,683.4 | 464,788.31 |
| 营业利润平衡项目 | 0 | 0 | 0 | 0 |
| 四、营业利润 | -28,310,589.67 | 3,098,409.35 | 20,095,123.47 | 22,267,603.3 |
| 加:营业外收入 | 1,039,197.9 | 12,550,174.2 | 9,804,122.65 | 9,000,900 |
| 减:营业外支出 | 24,438.05 | 32,121.74 | 23,068.3 | 20,000 |
| 利润总额平衡项目 | 0 | 0 | 0 | 0 |
| 五、利润总额 | -27,295,829.82 | 15,616,461.81 | 29,876,177.82 | 31,248,503.3 |
| 减:所得税费用 | - | 4,175,335.12 | 3,824,089.58 | 4,803,797.27 |
| 六、净利润 | -27,295,829.82 | 11,441,126.69 | 26,052,088.24 | 26,444,706.03 |
| 持续经营净利润 | -27,295,829.82 | 11,441,126.69 | 26,052,088.24 | 26,444,706.03 |
| 归属于母公司股东的净利润 | -25,996,930.16 | 17,555,561.77 | 30,283,759.85 | 28,546,071.06 |
| 少数股东损益 | -1,298,899.66 | -6,114,435.08 | -4,231,671.61 | -2,101,365.03 |
| (一)基本每股收益 | -0.06 | 0.04 | 0.07 | 0.07 |
| (二)稀释每股收益 | -0.06 | 0.04 | 0.07 | 0.07 |
| 九、综合收益总额 | -27,295,829.82 | 11,441,126.69 | 26,052,088.24 | 26,444,706.03 |
| 归属于母公司股东的综合收益总额 | -25,996,930.16 | 17,555,561.77 | 30,283,759.85 | 28,546,071.06 |
| 归属于少数股东的综合收益总额 | -1,298,899.66 | -6,114,435.08 | -4,231,671.61 | -2,101,365.03 |
| 公告日期 | 2024-04-26 | 2024-04-26 | 2023-10-27 | 2023-08-18 |
| 审计意见(境内) | | 标准无保留意见 | | |